These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 26162744)
1. UDP-hexose 4-epimerases: a view on structure, mechanism and substrate specificity. Beerens K; Soetaert W; Desmet T Carbohydr Res; 2015 Sep; 414():8-14. PubMed ID: 26162744 [TBL] [Abstract][Full Text] [Related]
2. The metastability of human UDP-galactose 4'-epimerase (GALE) is increased by variants associated with type III galactosemia but decreased by substrate and cofactor binding. Pey AL; Padín-Gonzalez E; Mesa-Torres N; Timson DJ Arch Biochem Biophys; 2014 Nov; 562():103-14. PubMed ID: 25150110 [TBL] [Abstract][Full Text] [Related]
3. Comparison of dynamics of wildtype and V94M human UDP-galactose 4-epimerase-A computational perspective on severe epimerase-deficiency galactosemia. Timson DJ; Lindert S Gene; 2013 Sep; 526(2):318-24. PubMed ID: 23732289 [TBL] [Abstract][Full Text] [Related]
4. Chemical and stereochemical actions of UDP-galactose 4-epimerase. Frey PA; Hegeman AD Acc Chem Res; 2013 Jul; 46(7):1417-26. PubMed ID: 23339688 [TBL] [Abstract][Full Text] [Related]
5. In silico prediction of the effects of mutations in the human UDP-galactose 4'-epimerase gene: towards a predictive framework for type III galactosemia. McCorvie TJ; Timson DJ Gene; 2013 Jul; 524(2):95-104. PubMed ID: 23644136 [TBL] [Abstract][Full Text] [Related]
6. The structural basis of substrate promiscuity in UDP-hexose 4-epimerase from the hyperthermophilic Eubacterium Thermotoga maritima. Shin SM; Choi JM; di Luccio E; Lee YJ; Lee SJ; Lee SJ; Lee SH; Lee DW Arch Biochem Biophys; 2015 Nov; 585():39-51. PubMed ID: 26344854 [TBL] [Abstract][Full Text] [Related]
7. 13C NMR analysis of electrostatic interactions between NAD+ and active site residues of UDP-galactose 4-epimerase: implications for the activation induced by uridine nucleotides. Wei Y; Lin J; Frey PA Biochemistry; 2001 Sep; 40(37):11279-87. PubMed ID: 11551228 [TBL] [Abstract][Full Text] [Related]
8. Molecular dynamics, residue network analysis, and cross-correlation matrix to characterize the deleterious missense mutations in GALE causing galactosemia III. Kumar SU; Sankar S; Kumar DT; Younes S; Younes N; Siva R; Doss CGP; Zayed H Cell Biochem Biophys; 2021 Jun; 79(2):201-219. PubMed ID: 33555556 [TBL] [Abstract][Full Text] [Related]
9. Mediators of galactose sensitivity in UDP-galactose 4'-epimerase-impaired mammalian cells. Schulz JM; Ross KL; Malmstrom K; Krieger M; Fridovich-Keil JL J Biol Chem; 2005 Apr; 280(14):13493-502. PubMed ID: 15701638 [TBL] [Abstract][Full Text] [Related]
11. Altered cofactor binding affects stability and activity of human UDP-galactose 4'-epimerase: implications for type III galactosemia. McCorvie TJ; Liu Y; Frazer A; Gleason TJ; Fridovich-Keil JL; Timson DJ Biochim Biophys Acta; 2012 Oct; 1822(10):1516-26. PubMed ID: 22613355 [TBL] [Abstract][Full Text] [Related]
12. Functional analysis of disease-causing mutations in human UDP-galactose 4-epimerase. Timson DJ FEBS J; 2005 Dec; 272(23):6170-7. PubMed ID: 16302980 [TBL] [Abstract][Full Text] [Related]
13. Molecular basis for severe epimerase deficiency galactosemia. X-ray structure of the human V94m-substituted UDP-galactose 4-epimerase. Thoden JB; Wohlers TM; Fridovich-Keil JL; Holden HM J Biol Chem; 2001 Jun; 276(23):20617-23. PubMed ID: 11279193 [TBL] [Abstract][Full Text] [Related]
14. Functional analysis of mutations in UDP-galactose-4-epimerase (GALE) associated with galactosemia in Korean patients using mammalian GALE-null cells. Bang YL; Nguyen TT; Trinh TT; Kim YJ; Song J; Song YH FEBS J; 2009 Apr; 276(7):1952-61. PubMed ID: 19250319 [TBL] [Abstract][Full Text] [Related]
15. Human UDP-galactose 4' epimerase (GALE) gene and identification of five missense mutations in patients with epimerase-deficiency galactosemia. Maceratesi P; Daude N; Dallapiccola B; Novelli G; Allen R; Okano Y; Reichardt J Mol Genet Metab; 1998 Jan; 63(1):26-30. PubMed ID: 9538513 [TBL] [Abstract][Full Text] [Related]
16. Crystal structures of the oxidized and reduced forms of UDP-galactose 4-epimerase isolated from Escherichia coli. Thoden JB; Frey PA; Holden HM Biochemistry; 1996 Feb; 35(8):2557-66. PubMed ID: 8611559 [TBL] [Abstract][Full Text] [Related]
17. Trypanosoma brucei UDP-galactose-4'-epimerase in ternary complex with NAD+ and the substrate analogue UDP-4-deoxy-4-fluoro-alpha-D-galactose. Alphey MS; Burton A; Urbaniak MD; Boons GJ; Ferguson MA; Hunter WN Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Sep; 62(Pt 9):829-34. PubMed ID: 16946458 [TBL] [Abstract][Full Text] [Related]
18. Structure of an antibiotic-synthesizing UDP-glucuronate 4-epimerase MoeE5 in complex with substrate. Sun H; Ko TP; Liu W; Liu W; Zheng Y; Chen CC; Guo RT Biochem Biophys Res Commun; 2020 Jan; 521(1):31-36. PubMed ID: 31653344 [TBL] [Abstract][Full Text] [Related]
19. Characterization of two mutations associated with epimerase-deficiency galactosemia, by use of a yeast expression system for human UDP-galactose-4-epimerase. Quimby BB; Alano A; Almashanu S; DeSandro AM; Cowan TM; Fridovich-Keil JL Am J Hum Genet; 1997 Sep; 61(3):590-8. PubMed ID: 9326324 [TBL] [Abstract][Full Text] [Related]
20. UDP-galactose 4-epimerase: NAD+ content and a charge-transfer band associated with the substrate-induced conformational transition. Liu Y; Vanhooke JL; Frey PA Biochemistry; 1996 Jun; 35(23):7615-20. PubMed ID: 8652544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]